CDH2 and non-small cell lung carcinoma: In addition, it can down-regulate PXN (paxillin) to suppress relapse in non-small cell lung cancer24 and down-regulate CDH2 (N-cadherin) expression16, which is associated with non-small cell lung cancer (NSCLC) metastatic spread to the brain25.